ChatCEO is the AI-powered operating system for the chief executive.
Sign up today.

Happy Sunday!
Texas took a big step toward a new era of nuclear power this week. Federal regulators approved a permit for Dow to build four advanced nuclear reactors at its chemical plant in Seadrift, south of Victoria.
It’s the first construction permit for a high-temperature gas-cooled reactor in nearly 60 years, and the first for an advanced nuclear facility at a U.S. industrial site. The reactors would provide both electricity and steam for Dow’s operations. There’s still a ways to go before construction begins, but it’s a significant milestone.
This week’s funding deals include Austin’s Nominal, which raised $240 million at a $3 billion valuation, triple what it was worth just eight months ago. The company makes software that helps engineers analyze data from complex machines and hardware, including aircraft, robots and nuclear reactors. At defense technology company Anduril, more than 300 engineers use Nominal’s platform, which has reduced some analysis tasks from five or six hours to nearly real time.
Before the full roundup below, our friends at pH Partners take a look at Kimberly-Clark’s massive $48.7 billion acquisition of Kenvue.
Kimberly-Clark Closes $48.7 Billion Kenvue Deal, Repositioning as a Consumer Health Company
Dallas-based Kimberly-Clark completed its acquisition of Kenvue on November 2, adding Tylenol, Listerine and Neutrogena to a portfolio that includes Huggies and Kleenex. The transaction was valued at approximately $48.7 billion in enterprise value at announcement, or 14.3x Kenvue’s LTM adjusted EBITDA, with more than 80% of the consideration paid in stock. Kenvue shareholders received $3.50 in cash and 0.146 Kimberly-Clark shares per Kenvue share and were expected to own about 46% of the combined company. Kimberly-Clark is converting a personal care business into a consumer health company, and the transaction combines $2.1 billion of targeted synergies with $3.1 billion of integration charges and unresolved Tylenol litigation.
Kimberly-Clark’s CEO described the acquisition as the next step in a portfolio shift toward higher-growth, higher-margin businesses. The combined portfolio holds 10 billion-dollar brands, and Kimberly-Clark projected approximately $32 billion of 2025 net revenue and approximately $7 billion of adjusted EBITDA at announcement. Kenvue contributed $15.1 billion of 2025 net sales.
Management reaffirmed the $2.1 billion run-rate synergy target after reinvestment. It consists of $1.9 billion of cost synergies within three years and $500 million of profit from revenue synergies within four years, with $300 million reinvested. The board approved an integration program on October 30 with approximately $3.1 billion of pre-tax charges through 2029, including $2.5 billion in cash. Supply chain network optimization is the largest cash item at approximately $0.8 billion, alongside approximately $1.4 billion of related capital spending.
Kimberly-Clark waited a year to add sector offerings its own brands did not cover. Its Huggies, Kotex, Depend and Kleenex franchises serve baby, feminine, adult and tissue needs. Kenvue adds the brands consumers turn to for pain relief, skin, oral and wound care, including Tylenol, Neutrogena, Listerine and Band-Aid, many of them recommended by healthcare professionals. Kimberly-Clark described Kenvue as positioned at the intersection of consumer goods and healthcare, and named baby care, women’s health and active aging among the categories it now leads.
pH Perspective
With this acquisition, Kimberly-Clark will offer some of the most recognized brands across consumer and health products. Beyond the obvious financial benefits that will be gained through eliminating redundancies across the combined companies, Kimberly-Clark is building trust with the consumer across additional categories. That trust will be valuable as consumers take greater control over their purchases in a health and wellness category that requires trust. This reinforces pH’s thesis that patients will continue to take more control over their health through intelligent purchases across consumer, health and wellness products.
-Analysis by pH Partners
pH Partners is an Austin-based boutique investment bank focused on Healthcare, Technology, and Consumer markets. Learn more at phpartners.com.
Deals
Austin
Nominal, a developer of a hardware intelligence platform for aerospace, defense and robotics engineering, raised $240M in a Series C co-led by Lightspeed Venture Partners and Insight Partners with participation from Sequoia Capital, General Catalyst, Founders Fund, Lux Capital, and others. $422.50M raised to date.
PromptPath, a developer of AI conversation intelligence software for automotive dealership staff coaching, raised $12M in a Series A co-led by FM Capital and Armory Square Ventures with participation from Automotive Ventures, Holman Ventures, and Assurant Ventures. $12M raised to date.
Arterra Pet Science (Leander), a developer of pet wellness products, including dental health supplements for dogs, raised $1.58M in an equity offering from undisclosed investors.
DegreeSight, a provider of credit transfer and degree audit software for higher education institutions, reported $1M sold in an equity offering from undisclosed investors. $4.78M raised to date.
Greater Texas Market
4Minds (Dallas), a provider of enterprise AI platforms building customer-owned knowledge graphs from business data, raised $15M in a Series A from Isom Holdings and Waterwood Capital Group. $17.14M raised to date.
TripleMoon (Dallas), a provider of telehealth behavioral health services embedded in pediatric primary care practices, raised $4M in a Seed extension co-led by LiveOak Ventures and Activate Venture Partners. $7.5M raised to date.
M&A
Austin
Encotech Engineering Consultants, an Austin-based multidisciplinary engineering firm specializing in mechanical, electrical, plumbing and structural engineering, was acquired by Trinity Consultants, a Dallas-based environmental and engineering consulting company. Encotech also has an office in San Antonio. Financial terms were not disclosed.
Greater Texas Market
Sempra Infrastructure Partners (Houston), an LNG and energy infrastructure company, saw parent Sempra complete the previously announced sale of a 45% equity interest to a KKR-led consortium with Canada Pension Plan Investment Board as an indirect co-investor. The base purchase price was approximately $10B, including cash at closing and deferred payments. The consortium now owns 65% of the company, while Sempra retains 25%. The transaction was originally agreed in September 2025.
NRG Energy (Houston), an electricity generation and energy services company, agreed to sell six natural gas power plants with a combined 4.9 GW of generating capacity to LS Power for $4B in cash, subject to adjustments. Three of the facilities are in Texas, with the others in New York, Rhode Island and Connecticut. Closing is expected in the second quarter of 2027.
Diamondback Energy (Midland), an oil and gas producer, and KKR agreed to acquire Five Point Infrastructure’s 70% interest in Deep Blue Midland Basin, a West Texas water sourcing, transportation, recycling and disposal platform. The deal is estimated by Reuters at $2.1B, although the companies did not officially disclose the price. Diamondback already owns the other 30%.
Archrock (Houston), a provider of natural gas compression and energy infrastructure services, agreed to acquire HiVolt Energy Holdings (Midland), a developer and operator of distributed power and microgrid infrastructure, for up to $450M in cash, consisting of $415M at closing and $35M in contingent earnout payments. Closing is expected in early 2027.
Dominion Bank (Dallas), a community bank with approximately $650M in assets, agreed to be acquired by First International Bank & Trust, a North Dakota-based bank entering the Texas market. The combined bank is expected to have approximately $7B in assets and 31 branches. The transaction is expected to close in early 2027. Financial terms were not disclosed.
Permian Basin Environmental Lab (PBELab) (Midland), an environmental laboratory providing soil and water testing for the Permian Basin, was acquired by Onterris, an Arkansas-based environmental services company. The transaction establishes Onterris’s first physical laboratory in the Permian Basin. Financial terms were not disclosed.
Texas Oral Surgery Specialists (Colleyville), an oral surgery and dental implant practice, was acquired by Texas Center for Oral Surgery & Dental Implants (Dallas), following the retirement of its founder. The location will become the buyer’s fifth North Texas practice. Financial terms were not disclosed.
See you next week!
—Mason & Joel
This edition was supported by Malik Osumah.
Subscribe to Joel Trammell’s CEO Newsletter, Managing the Future.






